Your SlideShare is downloading. ×
Digital Asset Management in Pharma
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Saving this for later?

Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime - even offline.

Text the download link to your phone

Standard text messaging rates apply

Digital Asset Management in Pharma

1,062
views

Published on

Published in: Technology, Business

0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,062
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
41
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Isaiah Campbell
  • 2. Landscape Changes DDMAC OPDPKey landscape questions• What’s your approval process? Can you report against it, or take action?• Who handles your marketing submissions today?• More than just a name change?• More compliance enforcement budget $ means more teeth?• New hurdles for prescription and direct to consumer products?• New rules for social media and internet?• What does this mean for new product, indications or our legacy?
  • 3. Current Landscape IntelligenceMore enforcement and compliance info requests Do you have the process, workflows, and dataDAM a key part of your brand integrity strategy You’re probably doing this today with other tools such as ZincPosition yourself to be successful Know what you’ll need to scale across current / future or acquired brands
  • 4. Maturity – Detail View Short Term • Centralized area with all graphics, video and other media. • Enable Search, Taxonomy, and Keywords. Asset Management • Cost savings by sharing assets among brands and agencies. • Extended data attributes support better management of assets with insight into (Brand Management, Agencies) expiration, royalties and license terms. • External collaboration between parties. Intermediate • Standard workflow process for design, submission and approval of Marketing Marketing Material Materials which contain a medical claim or other regulated messages. Review & Approval Workflow • Each brand has its own workspace (SharePoint site collections) • Material can be PDF, Video, Graphic, etc. (Brand Management, Agencies, • Work items for agencies are initiated in SharePoint or via InfoPath. Agencies work with brand to submit material for review/approval by participant who Medical Information) verifies medical claims. Long Term • Separate SharePoint Web Application > partitioned from rest of farm. • Approved materials moved via custom workflow action with select group of meta data, Compliance Archive versions. • Searchable database of all approved marketing materials by product, graphics, etc. (Legal, Regulatory) • Can be configured to assemble and push supporting materials to other systems including FDA. • Discoverable archive preserved for legal and regulatory purposes.
  • 5. Maturity Model – Simple View Asset Management Review and Approval Compliance Datamart• Centralized assets (graphics, video, etc) • Workflow for design, approval and • Approved materials tracker• Search, Taxonomy and Metadata internal approval of medical claims • Search and reports on datamart• Asset re-use and asset intelligence • Brand workspaces (optional) • Push to 3rd parties (IE Zinc MAPS)• External collaboration • Agency collaboration throughout • Discoverable and traceable lifecycle of work items
  • 6. What makes you success Tracking of approved messages Cradle to grave Central repository for assets Used by agencies in the production of marketing materials Reduced spend on media licensing and royalties sharing already owned assets across agencies/brands Build framework to extend the value of assets management system for upstream and downstream business value including compliance
  • 7. Where to start with ?  Digital Asset management “quick hits”  Single area to manage assets with brand management and agencies realizes immediate productivity gains.  Assets shared among brands and agencies maximize marketing spend for asset licensing and approval.  Taxonomy, keywords all support powerful Search capabilities.  Extended attributes support both reporting on license terms and potential to automate asset retirement using workflow.
  • 8. Why align with a larger strategy?  Intermediate and long term value  Standard process for working with agencies to produce and approve marketing material and digital assets.  Collaborate in the same platform (browser, SharePoint)  Continue to capture data about the lifecycle of assets by including in which material they are used.  Build a compliance engine for submission of data to FDA; archive these submissions electronically for lower cost electronic discovery production.
  • 9. SharePoint and Digital Asset Management  Life sciences has widely adopted SharePoint  SharePoint widely used in pharma (you own licenses today).  Rapid application development on platform lowers complexity.  Use search for ease of access, finding the right assets.  Extended asset attribute data is natively supported and aides development of lifecycle management tools and workflow.  Secure external access to collaborate with agencies is supported.  Can be a validated solution.  Ease of access using web browser, Microsoft Office and Adobe.  Integration other platforms & systems (Zinc)